Stocks and InvestingStocks and Investing
Wed, January 27, 2021
Tue, January 26, 2021
Mon, January 25, 2021
Fri, January 22, 2021

Raghuram Selvaraju Maintained (SPRO) at Strong Buy with Increased Target to $40 on, Jan 22nd, 2021


Published on 2024-10-27 15:19:15 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "Spero Therapeutics, Inc." (SPRO) at Strong Buy with Increased Target from $33 to $40 on, Jan 22nd, 2021.

Raghuram has made no other calls on SPRO in the last 4 months.



There are 2 other peers that have a rating on SPRO. Out of the 2 peers that are also analyzing SPRO, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Raghuram


  • Esther Hong of "Berenberg" Initiated at Strong Buy and Held Target at $47 on, Wednesday, December 16th, 2020
  • Josh Schimmer of "Evercore ISI Group" Initiated at Buy and Held Target at $70 on, Tuesday, September 29th, 2020